Ballentine Partners’s Adtran ADTN Stock Holding History

Ballentine Partners’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,771	Closed	-$93.9K	–	989
2025 Q1	$93.9K	Buy	+10,771	New	+$108K	﹤0.01%	860

Other funds holding ADTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Ballentine Partners's ADTN Position: Q2 2025 in Review

Ballentine Partners sold out of Adtran (ADTN) in Q2 2025, closing a stake of 10,771 shares — an estimated $93.9K sold.

Ballentine Partners first reported a position in ADTN in Q1 2025 and held it in 1 quarter. The position peaked at $93.9K in Q1 2025. 193 funds tracked by Wall St. Rank hold ADTN as of Q2 2025.

Ballentine Partners reported no remaining Adtran position as of Q2 2025 after selling out during the quarter.
Ballentine Partners sold 10,771 Adtran shares in Q2 2025, an estimated $93.9K.
Ballentine Partners first reported a position in Adtran in Q1 2025 and held it in 1 quarter.
Ballentine Partners's Adtran position peaked at $93.9K in Q1 2025.
193 funds tracked by Wall St. Rank held Adtran as of Q2 2025.

Based on Ballentine Partners's 13F filing for Q2 2025, filed 15 Jul 2025.